New drug ATB-320 enters first human tests for tough cancers
NCT ID NCT06933524
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This early-stage trial tests the safety of a new drug called ATB-320 in 24 adults with advanced solid tumors that have spread or are no longer responding to standard treatments. The main goal is to find the highest safe dose and identify any side effects. Participants will receive ATB-320 and be closely monitored for about a month.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.